Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
Date:10/24/2011

72.4434
E: deramian@ctiseattle.com
www.celltherapeutics.com/media.htm

Investors Contact:
Ed Bell
T: 206.282.7100
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.celltherapeutics.com/investors

Cell Therapeutics, Inc.Condensed Consolidated Statements of Operations(In thousands, except for per share amounts)(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Revenues:License and contract revenue$
-$
-$
-$
319Total revenues---319Operating expenses:Research and development7,5305,10126,98219,375Selling, general and administrative7,7607,89325,29739,378Total operating expenses15,29012,99452,27958,753Loss from operations(15,290)(12,994)(52,279)(58,434)Other income (expense):Investment and other income (expense), net29(23)54240Interest expense(204)(385)(855)(1,948)Amortization of debt discount and issuance costs(129)(166)(436)(600)Foreign exchange gain (loss)(1,133)1,000(56)(300)Debt conversion expense---(2,031)Net loss before noncontrolling interest(16,727)(12,568)(53,572)(63,073)Noncontrolling interest6546179149Net loss attributable to CTI(16,662)(12,522)(53,393)(62,924)Dividends and deemed dividends on preferred stock(13,023)(3,085)(49,817)(50,519)Net loss attributable to CTI common shareholders$ (29,685)$ (15,607)$
(103,210)$
(113,443)Basic and diluted net loss per common share $
(0.16)$
(0.13)$
(0.62)$
(1.03)Shares used in calculation of basic and diluted184,997118,591165,724109,874Balance Sheet Data:(amounts in thousands)September 30,December 31,20112010(unaudited)Cash and cash equivalents $
45,212$
22,649Working capital19,096(14,165)Total assets62,85053,592Convertible debt12,42922,308Accumulated deficit(1,696,917)(1,576,64
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
2. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
6. Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
7. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
8. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
9. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
10. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
(Date:1/14/2014)... January 14, 2014 During the 1600’s through ... as “The Doctor’s Plague.” In this time period, doctors did ... led, at times, to the death of vulnerable patients. In ... know that they may be unwittingly transmitting herpes viruses to ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... , the leading meeting place for buyers and sellers ... Pharma Sourcing Conference to be held December 6-7, 2011 ... The two day program will be jointly hosted by ... issues that global chemical and pharmaceutical industry players are ...
... 26, 2011 Immune Design Corp. (IDC), a ... immunotherapies for infectious disease, cancer and allergy, announced ... research collaboration with Sanofi-Aventis to investigate the use ... toll–like receptor 4 (TLR-4) agonist, in the field ...
... RICHMOND, Calif., Oct. 25, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... results and accomplishments. For the third quarter ... of $9.6 million, or $0.18 per share, compared to a ... the same period in 2010. As of September 30, 2011, ...
Cached Biology Technology:Informex Introduces a Thorough Global Pharma Perspectives Conference 2Sangamo BioSciences Reports Third Quarter 2011 Financial Results 2Sangamo BioSciences Reports Third Quarter 2011 Financial Results 3Sangamo BioSciences Reports Third Quarter 2011 Financial Results 4Sangamo BioSciences Reports Third Quarter 2011 Financial Results 5Sangamo BioSciences Reports Third Quarter 2011 Financial Results 6
(Date:7/9/2014)... Sexual selection refers to species, selection for traits ... type of natural selection enhances opportunities to mate, the ... Biologists at the University of California, Riverside have now ... of a placenta are linked. Describing the life ... the family Poeciliidae, the researchers found that species with ...
(Date:7/9/2014)... July 9, 2014Biofuels derived from the oils produced by ... fuels. To achieve this goal, optimization of cost effective ... pond systems, is needed. Sapphire Energy has developed an ... pond algae cultivation systems, described in Industrial Biotechnology ... publishers. The article is available on the Industrial ...
(Date:7/9/2014)... Guelph scientist that involved fitting bumblebees with tiny ... neonicotinoid pesticide hampers bees, ability to forage for ... professor in Guelph,s School of Environmental Sciences, and ... July 9 in the British Ecological Society,s journal ... how long-term pesticide exposure affects individual bees, day-to-day ...
Breaking Biology News(10 mins):Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Controlling contamination in open algae ponds for biofuels 2Bee foraging chronically impaired by pesticide exposure: Study 2
... Assist with Solutions and Services to Support U.S. Army,s ... International Inc (NYSE: CAI ) announced today ... support the U.S. Army,s Biometrics Task Force. CACI received ... and Support Services - Unrestricted (BOSS-U) contract vehicle. The ...
... strategic farming practices might be part of the solution ... on 15 January in Current Biology , a ... reflect sunlight back out to space, summertime temperatures could ... much of central North America and mid-latitude Eurasia. That ...
... Mean Time / 13:00 Eastern Standard Time (TORONTO): Scientists ... have detected evidence that DNA may not be the ... called epigenetics may also account for some inherited traits ... of genetics and inheritance, and potentially provide a new ...
Cached Biology News:CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services 2CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services 3CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services 4Strategic farming practices could help mitigate global warming 2Rethinking the genetic theory of inheritance 2
GOAT ANTI HUMAN PSA (ISOFORM 1)...
Human Carnosine Dipeptidase 1 Affinity Purified PAb...
... and P-selectin glycoprotein ligand-1 (PSGL-1) mediate the ... surface of endothelial cells at sites of ... of PSGL-1 in mediating the interaction between ... completely blocks recognition of PSGL-1 by either ...
Mouse Anti-Human MCAF-(MCP-1)...
Biology Products: